Clinical Trials in Meishan, China
Locations / Meishan, China
Delta Trials records 8 clinical trials conducted in Meishan, China, making it a notable site of clinical research activity. These trials across 15 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Meishan has changed over time.
8
Total Trials
15
Conditions
0
Terminated since 2020
Browse by condition (15 total)
- All Growth hormone deficiency in children trials
- Ischemic cerebral infarction 1 trialAll Ischemic cerebral infarction trials
- Alteplase 1 trialAll Alteplase trials
- Non-alcoholic steatohepatitis 1 trialAll Non-alcoholic steatohepatitis trials
- Growth hormone 1 trialAll Growth hormone trials
- Thrombosis 1 trialAll Thrombosis trials
- All Chronic obstructive pulmonary disease trials
- Basilar artery occlusion 1 trialAll Basilar artery occlusion trials
- Ischemic stroke, acute 1 trialAll Ischemic stroke, acute trials
- End stage renal disease (esrd) 1 trialAll End stage renal disease (esrd) trials
- Hbv 1 trialAll Hbv trials
- Hcc 1 trialAll Hcc trials
- Endovascular treatment 1 trialAll Endovascular treatment trials
- Growth hormone deficiency (ghd) 1 trialAll Growth hormone deficiency (ghd) trials
- Acute ischemic stroke 1 trialAll Acute ischemic stroke trials